Builds AI-powered virtual models of human cells using gigascale single-cell data to understand how drug molecules interact with diverse patient biology.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Tahoe builds AI-powered virtual models of human cells using gigascale single-cell data to understand how drug molecules interact with diverse patient biology. Their platform is designed to accelerate precision drug discovery, starting with cancer, by enabling the development of novel therapeutics through advanced biological modeling.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Tahoe Therapeutics Management Team
Investors
Mubadala Capital
Amplify Partners
General Catalyst
Databricks Ventures
Conviction
AIX Ventures
Wing Venture Capital
Civilization Ventures
Tahoe Therapeutics Valuations & Financials
View real-time NPM data on Tahoe Therapeutics stock including daily Tahoe Therapeutics stock price estimates, valuation history, and historical share price information. Access Tahoe Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Tahoe Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Tahoe Therapeutics? Get in touch to learn more.
Similar Companies
like Tahoe Therapeutics
FAQ
We have answers
Tahoe Therapeutics stock does not trade on public stock exchanges. Tahoe Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Tahoe Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Tahoe Therapeutics Stock does not trade on public stock exchanges. In order to sell Tahoe Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Tahoe Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Tahoe Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Tahoe Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Tahoe Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Tahoe Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Tahoe Therapeutics is a private company and has not had an IPO. There is currently no Tahoe Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Tahoe Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
